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and their extracellular antagonists in osteoarthritic  
human knee joint
Abstract
The osteophytes are bone spurs overgrowing the edge of the articular carti-
lage during the course of osteoarthritis (OA). The cellular mechanism of their 
development and growth resembles the intramembranous and endochondral 
bone development during embrional and postnatal normal bone development, 
growth, modeling, remodeling and repair. The role of BMPs in bone develop-
ment and metabolism is well documented and the members of the BMPs 
molecular network were recognized as important factors which could modu-
late new bone development and growth of osteophytes. The purpose of this 
study is to analyze the cooexpression of the most potent osteoinductive members 
of the BMP family (BMP-2, -4 and -7) and their extracellular antagonists 
gremlin, noggin, chordin, follistatin in order to establish their role during 
degenerative process of the synovial joints and growth of osteophyte.
In this study, the BMP-2, BMP-4, BMP-7, gremlin, noggin, chordin, 
follistatin expressions were analyzed in joint tissues from OA patients and 
from healthy individuals by immunohistochemistry and Western blot.
The immunohistochemistry showed different localization pattern of BMPs 
and BMP extracellular antagonists expressions in OA vs. normal joint tissues. 
In osteophyte, BMP-2 was not detected, while BMP-4 and BMP-7 were 
positive in hypertrophyc chondrocytes and osteocytes at the sites of endochon-
dral bone development. BMP-7 was strongly positive, while BMP-4 was 
negative in synovial membrane of OA joints. Gremlin, chordin and noggin 
were found in chondrocytes, osteoblasts of the osteophytic bone and synovial 
epithelium, while follistatin was found in chondrocytes, blood vessels and 
synovial epithelium.
Our result demonstrate the significant differences in BMPs and their an-
tagonists expression in normal tissues compare to joint tissue affected by OA 
and revealed how molecular balance of the local growth factors such as BMPs 
and their antagonists could be disturbed during degenerative processes. Also, 
these findings suggest the potent role of these molecular factors in pathogenesis 
of the OA and/or during growth and development of the human knee joint 
osteophytes.
IntroductIon
Bone morphogenesis is a unique process of bone tissue development, structure forming and maintaining in the whole human biology. This 
process is not exclusively ongoing during prenatal development and 
growth, but also it is repeated in adult life during bone modeling, remod-
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teresting since they can act locally and could prevent exces-
sive bone formation. Therefore they were recognized as 
potent molecules for pharmacological intervention in dis-
seases with excesses new bone formation such as ectopic 
bone formation or bone metastatic processes (23, 24). Local 
application of this molecules could antagonize endogenous 
osteoinductive signals and hypoteticaly could prevent os-
teophyte formation during osteoarthritis. In healthy bone 
and in healthy joint tissue local osteoinductive factors are 
in balance with the osteoinhibitory factors and certain feed-
back mechanism between these factors was proposed to 
have control of the bone homeostasis. Experimental data 
demonstrated different temporal and spatial localization of 
BMPs and their antagonist in normal and OA joint tissues. 
The role of BMPs in signaling during osteophyte formation 
has been extensively studied and it was revealed that each 
BMP has a distinct pattern of distribution in osteophytic 
and synovial tissues (25-28). Also, to date there are several 
reports, of the group of authors: Nakase, Tardif and Lories, 
about BMPs antagonists expression in OA joint tissues (29, 
30). However, to date no reports were published about co-
expression and localization of the most osteoinductive 
BMPs (BMP-2, -4 and -7) and their extracellular antago-
nists: noggin, gremlin, chordin and follistatin in osteo-
phytic tissue and synovial membrane of OA human knee 
joints. Therefore, in this study we explored the expression 
of these three most potent osteoinductive BMPs (BMP-2,-
4 and -7) and their extracellular antagonists in normal and 
OA human knee joint.
MAterIAl And Methods
tissue samples
For the purpose of this study osteophyte tissue, under-
lying bone tissue and synovial membrane tissue was col-
lected out of knee joints of 20 patients which underwent 
joint replacement surgery due to severe osteoarthritis (age 
was in range from 65 to 74 years). Informed consent was 
obtained from patients included in this study. Normal 
articular cartilage and subchondral bone were obtained 
from at an autopsy of individuals with no medical record 
of degenerative joint or metabolic bone diseases. Mineral-
ized tissue specimens were decalcified in Osteodec solu-
tion (during 5 days, at RT), washed in saline, fixed in 4% 
paraformaldehyde (24 hours) and embedded in paraffin. 
Using rotational microtome (Leica RM 2155, Leica In-
struments GmbH, Germany) tissue samples were cut on 
5 μm thick slices, mounted on silinated glass slides and 
processes for histology and immunohistochemistry. The 
study was approved by the Ethical Committee of the Fac-
ulty of medicine University of Rijeka.
Immunohistochemistry
Immunohistochemistry on tissue samples was per-
formed according to manufacturer instruction (Santa Cruz 
Biotechnology Inc.). The primary antibodies were pur-
nomenon underlying remarkable regenerative capacity of 
bone and is responsible for great capacity for skeletal ad-
aptation on different biomechanical loading (1). Also, bone 
morphogenesis occurs as a part of a joint repair attempt 
process during the degenerative processes of osteoarthritis 
(OA). During OA, bone morphogenesis lead to develop-
ment of newly formed bone spurs usually located at the 
margin of the articular cartilage known as osteophytes 
(1-3). Therefore, it is accepted to consider an osteophytic 
bone growth as a repair attempt during the degenerative 
process of articular cartilage breakdown and destruction 
of the synovial joints elements. Eventhough being the re-
sults of reparative processes in OA affected joints, osteo-
phytes restrict movements in affected joints and could be 
the cause of an existing pain in patients and therefore they 
are usually cut off during joint surgery. Still, the osteo-
phytic growth have tendency to repeat after that and cause 
problems furthermore.
Bone morphogenesis is complex and precisely regulated 
process modulated by systemic hormones, local growth fac-
tors and cytokines generated in the bone cell microenviron-
ment (4). A lot about molecular factors which regulate bone 
cells proliferation, differentiation, apoptosis and matrix 
synthesis during bone morphogenesis has been published 
previously. One of the most important factors involved in 
complex network of local growth and differentiational fac-
tors are the members of the bone morphogenetic proteins 
family (BMPs) (5-8). They act in an autocrine/paracrine 
manner and stimulate proliferation of osteoprogenitor stem 
cells, stimulate and promote differentiation of osteoblast 
cell lineage and stimulate synthesis of the bone matrix col-
lagenous and noncollagenous proteins (9). Their ability to 
stimulate bone morphogenesis is called osteoinductivity 
and therefore BMPs are characterized, beside other func-
tion, as osteoinductive (10,11). The most potent osteoinduc-
tive BMPs are BMP-2, BMP-4 and BMP-7 (12,13). As the 
other members of the BMP family, they act through spe-
cific cell surface receptors, bone morphogenetic protein 
receptors (BMPRs) which are phosphorilised upon BMP 
ligand binding (14,15). Upon that, signal transduction cas-
cade starts with phosphorylation of downstream cytosolic 
factors called Smad-s. Finally, activated Smads are translo-
cated into the cell nucleus and activate gene transcription-
al activity (16). BMP activity is precisely regulated in order 
to establish the fine balance between diverse functions of 
different bone cell. Recently, extracellular BMP antagonis-
tic factors were discovered, which bind directly to BMPs 
with high affinity and prevent BMP interaction with the 
specific receptors and therefore prevent BMPs effects on 
cells such as proliferation, differentiation and matrix syn-
thesis. These signaling molecules represent a group of struc-
turally unrelated extracellular secreted proteins (17,18). 
Follisatin, gremlin, chordin and noggin are such extracel-
lular BMP antagonists and much effort was done recently 
to explore their localization and function during bone mor-
phogenesis (19-22). Their antagonistic activity became in-
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chased from Santa Cruz Biotechnology Inc., USA and they 
were following polyclonal antibodies: goat anti-gremlin 
antibody (N-20), rabbit anti-noggin antibody (L-18Z), 
mouse anti-chordin antibody (K-25), mouse anti-follistatin 
antibody (H-114), mouse anti-BMP-2 (mAHuBMP-2) and 
anti-BMP-4 (N-16) and goat anti-BMP-7 antibody (T-12). 
Briefly, tissue slices were deparaffinized in xylene, rehi-
drated in ethanol and endogenous peroxidase activity was 
blocked by incubation in 0.3% H2O2 /methanol solution. 
Incubation in 5% normal non-immune serum was done in 
order to avoid background staining. Incubation with pri-
mary antibodies was done in humid chamber (60 minutes 
at room temperature), washed in PBS and secondary bioti-
nylated antibody was applied during 30 minutes, in humid 
chamber at room temperature. Thereafter, peroxidase con-
jugated streptavidin was added and the site of antigen bind-
ing was visualized using liquid DAB substrate chromogen. 
Sections were counterstained with hematoxyline and posi-
tive reaction of the antigen-.antibody reaction was seen as 
a dark brown staining. Staining specificity was determined 
by omission of the primary antibody and substitution of 
the primary antibody with an autologus pre-immune se-
rum. All control samples showed no antigen staining. Tis-
sue slices were dried and mounted in Histostain, analyzed 
with an Olympus BX 50 microscope (Olympus, Japan) and 
photographed using Olympus OM-4 Ti camera. Mor-
phometry was performed by counting the number of im-
munopositive cells for each antigen studied in this research, 
at 5 randomly chosen fields of 3 tissue slices 500μm distant 
from each other. The morphometric data were expressed as 
a percentage of total cell number that is stained positively 
for the antigen. The morphometric analysis was done by 
two independent observers (SZC, LD).
Western blot analysis
Tissue samples were homogenized, incubated with Ly-
sis buffer (30 minutes, 4°C) and centrifugired (30 min, 
12000 rpm, 4°C). Protein content of each sample was 
measured by spectrophotometry acording to the Bradford 
method. Electrophoresis was performed under reducing 
condition on 12%SDS polyacrylamid gel (SDS-PAGE) 
and then transblotted to nitrocellulose membrane using 
Transfer-blot semidray transfer cell (BIO-RAD, USA). 
Membranes were blocked with non-fat bovine milk (RT, 
120 min) and after that incubated with primary antibody 
diluted 1:200 in blocking buffer (RT, 24 hours). After 
washing in TBS membranes were incubated with second-
ary antibody described in previous section, diluted 1:2000 
(RT, 90 min). At the end, immunoblot was developed 
using chemiluminiscence and photographed on Agfa film.
results
histology of the osteophytes and 
synovial membrane
Tissue samples analyzed in this study were marginal 
osteophytes which are well developed and covered with 
Figure 1. Immunohistochemical localization of the osteoinductive BMP-2, -4 and -7 in osteophytes and synovial membrane in OA human knee 
joint. BMP-2 immunostaining showed no detectible signal nor in osteophyte (A) nither in synovial membrane (D). BMP-4 immunostaining 
showed positive chondrocytes in endochondral bone formation of the osteophytes (B) but the synovial tissue was negative (E). The strongest im-
munostaining was the BMP-7 in both osteophyte (C) and synovial membrane epithelium and stromal cells. Indirect immunoperoxidase stainig, 
counterstaining with hematoxyline, magnification 200 x.
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and cartilage cap and underlying immature woven bone 
tissue. They were characterized as mature forms of osteo-
phytes with a high content of newly formed bone tissue 
and covering hypertrophic cartilage. Synovial tissue 
showed no sign of inflammation or fibrosis (data not 
shown).
Immunohistochemical localization of 
the BMP-2, -4 and -7 in osteophyte and 
synovial membrane
The results of BMP-2, -4 and -7 immunohistochemical 
staining showed differences and specificity of localization 
in normal and osteoarthritic joint tissues. BMP-2 was not 
detected in osteophytic tissues or in synovial membrane 
(Figure 1 A, D), while BMP-4 and BMP-7 were positive 
in the hypertrophyc chondrocytes, cells and matrix of the 
superficial cartilage layer and also in osteocytes of the 
osteophytic bone tissue (Figure 1 B, C) (Table 1). Epithe-
lium of the synovial membrane was strongly positive only 
for BMP-7 (Figure 1 f), while BMP-2 was negative in both 
synovial epithelium and stromal cells (Figure 1 D). Con-
trol samples of the normal articular cartilage (Figure 3 A, 
B, C) and synovial tissues (data not shown) showed no 
detectable immunohistochemical reaction for BMPs or 
their inhibitors. Morphometrical analysis revealed that 
TaBle 1
The morphometrical results of the immunohistochemical expression of the BMPs (BMP –2, –4 and –7) 
and their antagonists (noggin, gremlin, follistatin and chordin) in developing human osteophytes and sy-
novial membrane of the knee joint. The results are presented as a percentage of immunohistochemical 
positive cells.
osteophyte synovial membrane
chondrocyte osteocyte epithelial cells stromal fibroblasts
BMP-2 0,25% / / /
BMP-4 32,15% / 50% 7,2%
BMP-7 52,55% / 97,36% 90%
noggin 29,75% 40% 100% 95%
gremlin 29,9% / 51% 20%
follistatin 8,65% / 69,25% 20,7%
chordin 12,4% / 100% 68,95%
Figure 2. Immunohistochemical localization of the folistatin (A, E), gremlin (B,F), noggin (C, G) and chordin (D,H) in osteophytes and syno-
vial membrane in OA human knee joint. Follistatin immunostaining showed positive cells in upper layer of osteophyte cartilage cap (A), and 
epithelium of the synovial membrane (E). Gremlin was found in chondrocytes, osteocytes of the woven bone (B) and synovial epithelium (F). 
Noggin was positive in chondrocytes (C) and synovial epithelium (G). Chordin was found to be positive in chondrocytes and osteoblasts (D), 
blood vessels and synovial epithelium (H). Indirect immunoperoxidase stainig, counterstaining with hematoxyline, magnification 200 x.
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BMP-4 was positive in 32,15% of the chondrocytes while 
BMP-7 expression was stronger with 52,55% immu-
nopositive chondrocytes. The stromal cells from OA sy-
novial membrane showed no detectable immunostaining 
for BMP-2, while BMP-4 had minimal immunostaining 
(7,05% cells). BMP-7 had the strongest expression found 
in 97,36% of the epithelial cell and in 90% of the stromal 
cells (Table 1).
Immunohistochemical localization of 
the BMP antagonists in osteophyte and 
synovial membrane
The results of imunohistochemical staining for BMP 
antagonists showed significant differences between differ-
ent BMP antagonists studied in this analysis and their 
different localization in osteophytic tissues and synovial 
membrane. Gremlin was found in chondrocytes, osteo-
blasts of the woven bone and synovial epithelium (Figure 
2. B, F). Chordin was found in chondrocytes and osteo-
blasts, blood vessels and synovial epithelium (Figure 2. 
D, H). Follistatin was found in upper layer of osteophyte 
cartilage cap, blood vessels and synovial epithelium (Fig-
ure 2. A, E). Noggin was positive in chondrocytes, osteo-
cytes and synovial epithelium (Figure 2. C, G). Mor-
phometry of the immunohistochemical results revealed 
that BMP antagonists have the strongest expression in 
chondrocytes: gremlin in 29,9%, noggin in 29,75%, fol-
listatin in 8,65% and chordin in 12,4% of total chondro-
cyte number. Gremlin, chordin and follistatin were 
negative in osteocytes and the only positive BMP antago-
nist in osteocytes was noggin which showed positivity in 
40% of osteocytes. Morphometry of immunohistochem-
ical staining of synovial membrane showed that noggin 
had maximal expression in epithelial and stromal cells of 
synovial membrane: 95% and 100% respectively, while 
chordin, had less intensive expression in stromal cells 
(68,95%) with maximal expression in epithelial cells. 
Gremlin and follistatin showed minor expression in ep-
itelial and stromal cells of synovial membrane (Table 1).
Figure 3. Immunohistochemical localization of the BMP-2 (A), -4 (B) and -7 (C), follistatin (D), gremlin (E), noggin (F) and chordin (G) in 
articular cartilage and subchondral bone of normal human knee joint. Indirect immunoperoxidase stainig, counterstaining with hematoxyline, 
magnification 200 x.
Figure 4. Western blot analysis of the protein expression for BMPs 
and their extracellular inhibitors in osteophyte (1st collumn) and 
synovial membrane (2nd collumn) in OA human knee joints. Pro-
tein expression in synovial membrane (3rd collumn) and sub-
chondal bone (4th collumn) of normal human knee joints (O – 
osteophyte, s.m. – synovial membrane, sh – subchondral bone).
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Western blot analysis
The results of immunobloting were consistent with im-
munohistochemistry. The Western blot analysis showed 
no detectible signal in normal joint tissue samples (Figure 
4, the third and fourth column) and positive signals for 
BMP-4, BMP-7, gremlin, follistatin, noggin and chordin 
in osteoarthritic joint tissue samples (Figure 4, the first 
and second column). The signal for BMP-2 was negative 
in OA tissue samples (Figure 4, the first line).
dIscussIon
In this study we have demonstrated existing coexpres-
sion of osteoinductive BMPs and their extracellular an-
tagonist, in OA human knee joint tissues. Also we have 
showed that these factors are differently expressed in dif-
ferent joint tissues osteophyte and synovial membrane. In 
our previous study we have already showed that among 
BMPs family members, BMP-2 and BMP-7 are two fac-
tors which have strongly specific localization in osteo-
phytes (25). BMP-2 is identified as a molecular factor 
which is specific for sites of intramembranous bone devel-
opment, while BMP-7, is strongly associated with carti-
lage and endochondral bone development sites (19). The 
present study showed similar results. BMP-2 was negative 
in osteophytic tissue which is in accordance with the fact 
that our samples of osteophytes were well developed with 
minimal amount of fibrous tissues and sites of intramem-
branous bone development. On the opposite, BMP-7 
showed strong expression in osteophytic tissue with spe-
cific localization in endochondral sites. This result is in 
accordance with well established chondrogenic role of the 
BMP-7. Therefore, BMP-7 positive expression in synovial 
membrane, both in stromal fibroblasts and epithelial cells, 
is expected and suggests that synovial membrane has im-
portant role in joint tissue metabolism, nourishment and 
growth factors production.
This study demonstrate positive expression of all four 
studied extracellular BMP antagonists in OA joint tissues, 
with the highest expression of gremlin and chordin in 
hypertrophic chondrocytes at the sites of endochondral 
bone development. In opposite, noggin and chordin 
showed higher expression in epithelium and stromal cells 
of the synovial membrane. These data suggest certain di-
versity in inhibitory role of different BMPs antagonists 
and could have a significant importance in pathogenesis 
of OA and osteophyte development.
There are several reports that have demonstrated dif-
ferent expression of the extracellular BMPs antagonists in 
articular cartilage and synovial tissue during degenerative 
and inflammatory processes in synovial joints. Nakase et 
al. have found positive BMP-2 expression in early mes-
enchimal layers and fibrochondrocytes of the osteophyte 
which coresponded to intramembranous bone formation 
sites while BMP-2 was negative in chondrocytes close to 
bone forming sites i.e. endochondral bone formation sites 
(30). Tardif et al. have showed different expression of fol-
listatin, chordin and gremlin in osteoarthritic cartilage 
and synovial fibroblast and suggested that their increased 
activities appearing in different stages of OA process may 
reflect different roles in this disease (29). Lories et al. have 
showed the importance of noggin in destructive and re-
modeling arthritis (24).
Conclusively, the results of our study confirmed high 
activity of BMP-4 and -7 during endochondral bone de-
velopment in osteophytes and in the synovium of OA 
joints. The results of immunohistochemical detection of 
chordin, follistatin, noggin and gremlin suggest that these 
BMP antagonists are up-regulated in both osteophyte and 
synoval membrane of OA joints, with emphasis on noggin 
and chordin. The precise role of these molecular factors 
in the bone morphogenesis has not been elucidated yet, 
and there are still unanswered questions concerning the 
balance between the local molecular factors involved in 
bone morphogenesis during pathological processes of the 
joint tissues. Different role of chordin, follistatin, noggin 
and gremlin in molecular network where interaction with 
other local growth and differentiational factors are ex-
pected, should be taken into consideration for the possible 
usefulness of these BMP antagonists in prevention of the 
excessive processes of bone formation in OA and other 
skeletal disorders.
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